Ross Mitchell - Brainsway Vice Marketing

BWAY Stock  USD 9.55  0.16  1.70%   

Executive

Ross Mitchell is Vice Marketing of Brainsway
Address Bynet Building, Jerusalem, Israel, 9777518
Phone972 2 582 4030
Webhttps://www.brainsway.com

Brainsway Management Efficiency

The company has return on total asset (ROA) of 0.0108 % which means that it generated a profit of $0.0108 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0352 %, meaning that it created $0.0352 on every $100 dollars invested by stockholders. Brainsway's management efficiency ratios could be used to measure how well Brainsway manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.06 in 2025. Return On Capital Employed is likely to drop to -0.09 in 2025. At this time, Brainsway's Non Currrent Assets Other are fairly stable compared to the past year. Total Current Assets is likely to rise to about 67 M in 2025, whereas Total Assets are likely to drop slightly above 42.3 M in 2025.
Brainsway currently holds 471 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Brainsway has a current ratio of 6.71, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Brainsway's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Daniel JDOrthopediatrics Corp
55
Jason RaserVenus Concept
N/A
Matthew BrinckmanParagon 28
N/A
Robert JDParagon 28
58
Andres CedronOrthofix Medical
44
RN MBACVRx Inc
N/A
Matthew MillardParagon 28
N/A
Jerry SauberTactile Systems Technology
N/A
Jonathan FriedmanParagon 28
53
Vojislav MDDelcath Systems
57
Michael MandarelloVenus Concept
40
MD FACSTactile Systems Technology
N/A
Julie AndrewsOrthofix Medical
54
David HoffmanDelcath Systems
N/A
Johnny MDDelcath Systems
60
Bradley NagelElectromed
43
Martha RookDelcath Systems
54
Kristie BurnsTactile Systems Technology
52
Robert ThomsonArtivion
55
Ray GarrisonOrthopediatrics Corp
N/A
William McGrailVenus Concept
64
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 118 people. Brainsway (BWAY) is traded on NASDAQ Exchange in USA. It is located in Bynet Building, Jerusalem, Israel, 9777518 and employs 134 people. Brainsway is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Brainsway Leadership Team

Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Jako, Pres CEO
Ido Marom, Chief Officer
Gilead Moiseyev, Chief Officer
Moria Ankri, VP RD
Dor Hagai, Vice Operations
Pr Zangen, Member CoFounder
Hillegonda Groen, Vice Sales
Ross Mitchell, Vice Marketing
Richard MD, Chief Officer
Menachem Esq, General VP
Avner Hagai, Founder ViceChairman
Christopher Boyer, Vice Marketing
Hadar Levy, Chief Officer
Yiftach Roth, Chief Scientist
Aron Tendler, Chief Officer
Richard Areglado, VP CFO

Brainsway Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Brainsway Stock Analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.